Feasibility of Bariatric Surgery as a Strategy for Secondary Prevention in Cardiovascular Disease: A Report from the Swedish Obese Subjects Trial

Table 1

Anthropometrics and prevalence of cardiovascular risk factors (%) in the surgery and control groups at baseline and changes in prevalence after 2 and 10 years of follow-up. Only the patients applicable for the certain timepoint are included in the statistical calculations.

	Baseline	Change at 2-year follow-up	Change at 10-year follow-up
	Surgery $n=21$	Surgery, $n=21$	Surgery, $n=13$
	Control $n=14$	Control, $n=13$	Control, $n=8$
Weight, kg
Surgery	122.8 $\pm$ 15	$-$26.3 $\pm$ 14.7${}^{***}$	$-$17.3 $\pm$ 13.1${}^{*}$
Control	115.3 $\pm$ 18	$-$2.3 $\pm$ 5.2	$-$4.3 $\pm$ 5.2
BMI, kg/m^2
Surgery	40.6 $\pm$ 4.3	$-$8.6 $\pm$ 4.8${}^{***}$	$-$5.6 $\pm$ 4.2${}^{*}$
Control	38.0 $\pm$ 4.5	$-$0.8 $\pm$ 1.8	$-$1.5 $\pm$ 2.0
Waist circumference, cm
Surgery	128.3 $\pm$8.3	$-$21.2 $\pm$12.5	$-$12.9 $\pm$12.2
Control	123.5$\pm$9.1	$-$12.9 $\pm$12.2	$-$3.7 $\pm$ 6.0
Current smoker %
Surgery	52.4	$-$20.0${}^{*}$	$-$18.2
Control	50.0	$-$14.8	$-$22.2
Hypertension %
Surgery	57.1	$-$15.0${}^{***}$	$-$23.1${}^{*}$
Control	53.8	21.2	0
Dyslipidemia %
Surgery	95.2	$-$28.5${}^{***}$	$-$69.2
Control	92.9	0	$-$22.2
Diabetes %
Surgery	52.4	$-$14.3${}^{***}$	$-$7.7${}^{***}$
Control	50.0	0	11.1

P-value denotes differences in effects of treatment between the two groups from baseline to 2 and 10 years of follow-up. ${}^{*}$$P\mathrm{\hspace{0.17em}\hspace{0.17em}}<.05\text{,}$${}^{***}$$P\mathrm{\hspace{0.17em}\hspace{0.17em}}<.001$.